• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于血管内介入治疗的肱动脉和腋动脉血管通路

Brachial and Axillary Artery Vascular Access for Endovascular Interventions.

作者信息

Lentz Charlotte M, Zogaj Donika, Wessel Hanna K, Zeebregts Clark J, Bokkers Reinoud P H, van der Laan Maarten J

机构信息

Division of Vascular Surgery, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Department of Radiology, Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

出版信息

Ann Vasc Surg. 2022 Apr;81:292-299. doi: 10.1016/j.avsg.2021.09.052. Epub 2021 Nov 11.

DOI:10.1016/j.avsg.2021.09.052
PMID:34775017
Abstract

BACKGROUND

Endovascular access is usually achieved through the common femoral artery due to its large size and accessibility. Access through the upper extremity can however be necessary due to anatomic reasons, obesity, or peripheral arterial disease. The 2 main methods of access are surgical cutdown and percutaneous puncture. In this single-centre retrospective cohort study we compared complication risks for both surgical cutdown and percutaneous puncture of an upper arm approach.

MATERIALS AND METHODS

Data was obtained from patients receiving endovascular access through the brachial or axillary artery between 2005 and 2018. A total of 109 patients were included. Patient demographics including age, sex, medical history, smoking status, and actual medication were registered, as well as postoperative complications including hematoma, thrombosis, dissection, infection, pseudoaneurysm, nerve injury, reoperation, and readmission.

RESULTS

Access was achieved through surgical cutdown in 53% (n = 58) and through percutaneous puncture in 47% (n = 51) of patients. Fifty-eight percent (n = 63) received access via the brachial artery (BA) and 42% (n = 46) via the axillary artery. Complication rate was 25.0% (3 of 12) for surgical cutdown via the BA, 29.4% (15 of 51) for percutaneous puncture via the BA, and 10.9% (5 of 46) for surgical cutdown via the axillary artery. Major complication rate was 8.3% (1 of 12) for surgical cutdown via the BA, 13.7% (7 of 51) for percutaneous puncture via the BA, and 4.3% (2 of 46) for surgical cutdown via the axillary artery. There was no association between baseline patient characteristics and complication rate.

CONCLUSIONS

In this nonrandomized retrospective study, surgical cutdown via the axillary artery was the safest option with fewest complications, but selection of patients may have blurred the results. Surgical cutdown and percutaneous puncture seem equally safe in terms of complication rate in the BA.

摘要

背景

由于股总动脉管径大且易于触及,血管内介入通路通常经此建立。然而,由于解剖学原因、肥胖或外周动脉疾病,上肢入路可能是必要的。两种主要的入路方法是外科切开和经皮穿刺。在这项单中心回顾性队列研究中,我们比较了上臂入路的外科切开和经皮穿刺的并发症风险。

材料与方法

数据来自2005年至2018年间通过肱动脉或腋动脉接受血管内介入通路的患者。共纳入109例患者。记录患者的人口统计学信息,包括年龄、性别、病史、吸烟状况和实际用药情况,以及术后并发症,包括血肿、血栓形成、夹层、感染、假性动脉瘤、神经损伤、再次手术和再次入院。

结果

53%(n = 58)的患者通过外科切开建立通路,47%(n = 51)的患者通过经皮穿刺建立通路。63%(n = 63)的患者通过肱动脉(BA)入路,42%(n = 46)的患者通过腋动脉入路。经肱动脉外科切开的并发症发生率为25.0%(12例中的3例),经肱动脉经皮穿刺的并发症发生率为29.4%(51例中的15例),经腋动脉外科切开的并发症发生率为10.9%(46例中的5例)。经肱动脉外科切开的主要并发症发生率为8.3%(12例中的1例),经肱动脉经皮穿刺的主要并发症发生率为13.7%(51例中的7例),经腋动脉外科切开的主要并发症发生率为4.3%(46例中的2例)。患者基线特征与并发症发生率之间无关联。

结论

在这项非随机回顾性研究中,经腋动脉外科切开是并发症最少的最安全选择,但患者的选择可能使结果模糊。就肱动脉入路的并发症发生率而言,外科切开和经皮穿刺似乎同样安全。

相似文献

1
Brachial and Axillary Artery Vascular Access for Endovascular Interventions.用于血管内介入治疗的肱动脉和腋动脉血管通路
Ann Vasc Surg. 2022 Apr;81:292-299. doi: 10.1016/j.avsg.2021.09.052. Epub 2021 Nov 11.
2
Arterial cutdown reduces complications after brachial access for peripheral vascular intervention.动脉切开术可减少外周血管介入治疗中经肱动脉穿刺后的并发症。
J Vasc Surg. 2016 Jul;64(1):149-54. doi: 10.1016/j.jvs.2016.02.019. Epub 2016 Mar 23.
3
Percutaneous axillary artery access for endovascular interventions.经皮腋动脉入路在血管内介入治疗中的应用。
J Vasc Surg. 2018 Aug;68(2):555-559. doi: 10.1016/j.jvs.2017.11.066. Epub 2018 Feb 2.
4
Outcomes of Brachial Artery Access for Endovascular Interventions.用于血管内介入治疗的肱动脉入路的治疗效果。
Ann Vasc Surg. 2019 Apr;56:81-86. doi: 10.1016/j.avsg.2018.07.061. Epub 2018 Oct 19.
5
Safety and Effectiveness of Percutaneous Axillary Artery Access for Complex Aortic Interventions.经皮腋动脉入路用于复杂主动脉介入治疗的安全性和有效性
Ann Vasc Surg. 2019 Nov;61:326-333. doi: 10.1016/j.avsg.2019.05.046. Epub 2019 Aug 5.
6
Superficial femoral artery access for endovascular aortic repair.经股浅动脉入路行血管腔内主动脉修复术。
J Vasc Surg. 2020 May;71(5):1538-1545. doi: 10.1016/j.jvs.2019.07.081. Epub 2019 Nov 4.
7
Superficial Femoral Artery Access for Infrainguinal Antegrade Endovascular Interventions in the Hostile Groin: A Prospective Randomized Study.股浅动脉入路在复杂腹股沟区经皮腔内血管重建中的应用:一项前瞻性随机研究。
Ann Vasc Surg. 2022 Oct;86:127-134. doi: 10.1016/j.avsg.2022.04.017. Epub 2022 Apr 20.
8
Safety and learning curve of percutaneous axillary artery access for complex endovascular aortic procedures.经皮腋动脉入路在复杂主动脉血管内治疗程序中的安全性和学习曲线。
J Vasc Surg. 2024 Mar;79(3):487-496. doi: 10.1016/j.jvs.2023.10.048. Epub 2023 Oct 31.
9
Axillary Artery Access as an Adjunct for Complex Endovascular Aortic Repair.腋动脉入路作为复杂血管腔内主动脉修复术的辅助手段
Ann Vasc Surg. 2015 Nov;29(8):1543-7. doi: 10.1016/j.avsg.2015.05.024. Epub 2015 Jul 13.
10
Direct percutaneous access technique for transaxillary transcatheter aortic valve implantation: "the Hamburg Sankt Georg approach".经皮直接入路技术在经腋动脉经导管主动脉瓣植入术中的应用:“汉堡圣乔治方法”。
JACC Cardiovasc Interv. 2012 May;5(5):477-486. doi: 10.1016/j.jcin.2011.11.014.

引用本文的文献

1
Percutaneous Cannulation of the Axillary Artery: Does the Position of the Brachial Plexus Correlate With Bony Landmarks That Could Be Used to Reduce the Risk of Complications?腋动脉的经皮插管:臂丛神经的位置与可用于降低并发症风险的骨性标志有关吗?
Cureus. 2024 Aug 27;16(8):e67926. doi: 10.7759/cureus.67926. eCollection 2024 Aug.